Jaguar Health Exchanges 7.96 Series Q Preferred for 54,222 Common Shares
Jaguar Health, Inc. completed two privately negotiated exchange agreements with Streeterville Capital, LLC, issuing a total of 54,222 shares of common stock in exchange for 7.96 shares of Series Q Perpetual Preferred Stock. The preferred shares were subsequently cancelled and retired. Additionally, the company adjourned its 2026 Annual Meeting of Stockholders from May 22, 2026, until June 2, 2026, to provide further information to shareholders regarding certain proposals, following discussions with The Nasdaq Stock Market LLC. A supplement to the proxy statement will be filed before the reconvened meeting.
Key Highlights
- Jaguar Health issued 54,222 common shares to Streeterville Capital, LLC.
- The common shares were exchanged for 7.96 shares of Series Q Preferred Stock.
- The 7.96 Series Q Preferred Shares were cancelled and retired upon exchange.
- The 2026 Annual Meeting of Stockholders was adjourned from May 22 to June 2, 2026.
- Adjournment was to provide additional information to stockholders after Nasdaq discussions.
- A supplement to the Proxy Statement will be filed prior to the reconvened meeting.
Price Impact
More from JAGX
Jaguar Health Completes Series O Preferred Stock Conversion; 4.86M Common Shares Outstanding
Jaguar Health Converts Series O Preferred Stock to Common
Jaguar Health Explores Strategic Alternatives for Rare Disease Program